CLSD has been granted a new patent
Jan 29, 2025, 11:36 PM
-3.37%
What does CLSD do
Clearside Biomedical, headquartered in Alpharetta, Georgia, specializes in therapies delivered to the eye via the suprachoroidal space and has developed the approved product XIPERE. The company’s lead program, CLS-AX, is in Phase 2b clinical testing for wet AMD.
CLSD filed a patent for "compositions comprising axitinib and methods of treating ocular disorders" on Tue, July 18, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.